Screening Mammography for 40-Year-Old Women—Whose Decision?

This Viewpoint discusses the potential risks and benefits for starting screening at 40 rather than 50 years of age and whether clinicians or patients should decide based on risk rather than age.

Authors

Institutions

Publication Details

Journal
JAMA Internal Medicine
Published
2024-09-03
DOI
https://doi.org/10.1001/jamainternmed.2024.4277
Citations
1
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Screening Mammography for 40-Year-Old Women—Whose Decision?

Jeffrey A. Tice, Karla Kerlikowske, Laura J. Esserman
1 citations
JAMA Internal Medicine
Global Cancer Incidence and Screening
0.28
article

Screening Mammography for 40-Year-Old Women—Whose Decision?

Jeffrey A. Tice, Karla Kerlikowske, Laura J. Esserman
article en
1 citations

Abstract

This Viewpoint discusses the potential risks and benefits for starting screening at 40 rather than 50 years of age and whether clinicians or patients should decide based on risk rather than age.

JAMA Internal MedicineVol. 184(11)
San Francisco VA Medical Center (US), University of California, San Francisco (US)
Gender equality
Openalex Percentile: Top 36%
Global Cancer Incidence and Screening
0.28
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Screening Mammography for 40-Year-Old Women—Whose Decision? — Jeffrey A. Tice, Karla Kerlikowske, et al. · JAMA Internal Medicine (2024) | TGRS Research Map | TGRS